Further indications of the importance of the subcellular localization of PKCδ to its function was recently demonstrated by a study reporting its role in EGFR TK inhibitor resistance when localized in the nucleus in non–small cell lung cancer (Lee et al., 2018). This evidence concerns the gene EGFR and lung cancer.